Cough
Not recruitingStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
- Disease:Cough
- Substances:Camlipixant
Hungary- Participants:18–64 years · 65+ years
- Substances:Camlipixant
- Sponsor:Bellus Health Inc.
Rare diseases
Investigational molecules
Locations
Back to Hungary25 clinical trials in Hajdunanas, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Multiple studies focusing on moderate-to-severe asthma management and treatment innovations. Research includes evaluation of novel therapeutics like lunsekimig and amlitelimab for improving patient outcomes.
Studies aim to enhance long-term respiratory function and reduce asthma attacks in patients with inadequate symptom control.
Comprehensive research into Chronic Obstructive Pulmonary Disease treatments, investigating both established and innovative therapies through various combination treatments and delivery methods.
Investigations focus on improving quality of life and respiratory function in moderate to severe COPD patients.
Specialized studies addressing various respiratory challenges, including chronic cough and complex pulmonary conditions requiring targeted therapeutic approaches.
Research emphasizes innovative treatment approaches and long-term safety monitoring for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.